: +103% Gains were driven by breakthroughs in cystic fibrosis treatments and robust revenue growth.
These large-cap companies led the market based on total annual returns:
: +132% A utility play that successfully executed a massive "transformation plan" involving debt reduction and asset sales.
: Biotech and pharmaceutical companies like Vertex saw triple-digit returns due to clinical trial breakthroughs.
: +81% Like D.R. Horton, this homebuilder benefited from a strong construction cycle and record consumer confidence levels. Market Context and Trends
: +89% The top performer in the Dow Jones Industrial Average, fueled by record commercial jet demand and improved operational efficiency.